Impact of prior smoking exposure and COPD comorbidity on treatment response to monoclonal antibodies in patients with severe asthma

Patients suffering from severe asthma may benefit from an antibody treatment irrespective of their status as an ex-smoker https://bit.ly/3fYC8tC

Detalles Bibliográficos
Autores principales: Morobeid, Heba, Pizarro, Carmen, Biener, Leonie, Ulrich-Merzenich, Gudrun, Kütting, Daniel, Nickenig, Georg, Skowasch, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365141/
https://www.ncbi.nlm.nih.gov/pubmed/34409092
http://dx.doi.org/10.1183/23120541.00190-2021
_version_ 1783738646464036864
author Morobeid, Heba
Pizarro, Carmen
Biener, Leonie
Ulrich-Merzenich, Gudrun
Kütting, Daniel
Nickenig, Georg
Skowasch, Dirk
author_facet Morobeid, Heba
Pizarro, Carmen
Biener, Leonie
Ulrich-Merzenich, Gudrun
Kütting, Daniel
Nickenig, Georg
Skowasch, Dirk
author_sort Morobeid, Heba
collection PubMed
description Patients suffering from severe asthma may benefit from an antibody treatment irrespective of their status as an ex-smoker https://bit.ly/3fYC8tC
format Online
Article
Text
id pubmed-8365141
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-83651412021-08-17 Impact of prior smoking exposure and COPD comorbidity on treatment response to monoclonal antibodies in patients with severe asthma Morobeid, Heba Pizarro, Carmen Biener, Leonie Ulrich-Merzenich, Gudrun Kütting, Daniel Nickenig, Georg Skowasch, Dirk ERJ Open Res Research Letters Patients suffering from severe asthma may benefit from an antibody treatment irrespective of their status as an ex-smoker https://bit.ly/3fYC8tC European Respiratory Society 2021-08-16 /pmc/articles/PMC8365141/ /pubmed/34409092 http://dx.doi.org/10.1183/23120541.00190-2021 Text en Copyright ©The authors 2021 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
spellingShingle Research Letters
Morobeid, Heba
Pizarro, Carmen
Biener, Leonie
Ulrich-Merzenich, Gudrun
Kütting, Daniel
Nickenig, Georg
Skowasch, Dirk
Impact of prior smoking exposure and COPD comorbidity on treatment response to monoclonal antibodies in patients with severe asthma
title Impact of prior smoking exposure and COPD comorbidity on treatment response to monoclonal antibodies in patients with severe asthma
title_full Impact of prior smoking exposure and COPD comorbidity on treatment response to monoclonal antibodies in patients with severe asthma
title_fullStr Impact of prior smoking exposure and COPD comorbidity on treatment response to monoclonal antibodies in patients with severe asthma
title_full_unstemmed Impact of prior smoking exposure and COPD comorbidity on treatment response to monoclonal antibodies in patients with severe asthma
title_short Impact of prior smoking exposure and COPD comorbidity on treatment response to monoclonal antibodies in patients with severe asthma
title_sort impact of prior smoking exposure and copd comorbidity on treatment response to monoclonal antibodies in patients with severe asthma
topic Research Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365141/
https://www.ncbi.nlm.nih.gov/pubmed/34409092
http://dx.doi.org/10.1183/23120541.00190-2021
work_keys_str_mv AT morobeidheba impactofpriorsmokingexposureandcopdcomorbidityontreatmentresponsetomonoclonalantibodiesinpatientswithsevereasthma
AT pizarrocarmen impactofpriorsmokingexposureandcopdcomorbidityontreatmentresponsetomonoclonalantibodiesinpatientswithsevereasthma
AT bienerleonie impactofpriorsmokingexposureandcopdcomorbidityontreatmentresponsetomonoclonalantibodiesinpatientswithsevereasthma
AT ulrichmerzenichgudrun impactofpriorsmokingexposureandcopdcomorbidityontreatmentresponsetomonoclonalantibodiesinpatientswithsevereasthma
AT kuttingdaniel impactofpriorsmokingexposureandcopdcomorbidityontreatmentresponsetomonoclonalantibodiesinpatientswithsevereasthma
AT nickeniggeorg impactofpriorsmokingexposureandcopdcomorbidityontreatmentresponsetomonoclonalantibodiesinpatientswithsevereasthma
AT skowaschdirk impactofpriorsmokingexposureandcopdcomorbidityontreatmentresponsetomonoclonalantibodiesinpatientswithsevereasthma

Ejemplares similares